---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285977061.md"
description: "Exagen shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 sales guidance."
datetime: "2026-05-11T16:14:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285977061.md)
  - [en](https://longbridge.com/en/news/285977061.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285977061.md)
generator: "portal-rs"
---

# 

Exagen shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 sales guidance.

### Related Stocks

- [XGN.US](https://longbridge.com/en/quote/XGN.US.md)

## Related News & Research

- [A Peek at Exagen's Future Earnings](https://longbridge.com/en/news/278426924.md)
- [Exagen Earnings Report: Q4 Overview](https://longbridge.com/en/news/278551881.md)
- [Is Procter & Gamble Stock Underperforming the Nasdaq?](https://longbridge.com/en/news/297406975.md)
- [What smart people are saying about Meta's settlement](https://longbridge.com/en/news/297137247.md)
- [Royce Small-Cap Trust (NYSE: RVT) as of Jul 31, 2026 | RVT Stock News](https://longbridge.com/en/news/296946273.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**